Skip to main content
Covalon Technologies Ltd. logo

Covalon Technologies Ltd. — Investor Relations & Filings

Ticker · COV ISIN · CA22282D3022 TSXV Manufacturing
Open in API
Filings indexed 152 across all filing types
Latest filing 2025-01-07 Audit Report / Informat…
Country CA Canada
Listing TSXV COV

About Covalon Technologies Ltd.

https://covalon.com/

Covalon Technologies Ltd. researches, develops, manufactures, and commercializes innovative medical devices and healthcare technologies. The company specializes in three core areas: infection management, advanced wound care, and vascular access. Covalon's portfolio includes advanced silicone dressings, specialized coatings, and surgical consumables designed to prevent, detect, and manage medical conditions. Utilizing patented, breakthrough technologies, Covalon aims to transform patient care by prioritizing healing, comfort, and safety, particularly in clinical settings requiring robust infection control and tissue repair solutions.

Recent filings

Filing Released Lang Actions
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 1% confidence The document is the Independent Auditor’s Report on BluSky Carbon Inc.’s consolidated financial statements, including the auditor’s opinion, key audit matters, notes, and full financial statements for the years ended August 31, 2024 and 2023. It is a standalone audit report rather than an annual report narrative or a brief announcement. This matches the definition of a standalone Audit Report / Information. FY 2024
2025-01-07 English
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a business news release titled “Covalon Announces Strong Fourth Quarter and Year End Fiscal 2024 Results,” summarizing headline Q4 and full‐year fiscal financial metrics (revenue, gross profit, Adjusted EBITDA, EPS), providing bullet‐point highlights, a CEO quote, and details of an upcoming conference call. This format and content correspond to an initial earnings announcement rather than a full interim report, transcript, or regulatory filing, matching the definition of an Earnings Release (ER). Q4 2024
2025-01-07 English
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 1% confidence The document is a TSX Trust Company notice sent to exchanges and commissions confirming the record and meeting dates for Covalon Technologies Ltd’s upcoming Annual General Meeting. It does not contain AGM materials, voting results, or a full proxy statement—it is a regulatory announcement of meeting logistics. This fits the fallback category for general regulatory filings (RNS).
2025-01-02 English
News release - English.pdf
Report Publication Announcement Classification · 1% confidence The document is a press/news release announcing the date and logistics of the upcoming release of the company’s Q4 and year-end 2024 financial results and the related conference call/webcast. It does not contain the actual financial results, neither is it the transcript nor the report itself. Instead, it serves to announce the timing and availability of the report and call, which matches the definition of a Report Publication Announcement (RPA).
2024-12-19 English
News release - English.pdf
Regulatory Filings
2024-10-30 English
News release - English.pdf
Regulatory Filings
2024-09-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.